Add BrightSurf on Google Email

Solving mystery of rare cancers directly caused by HIV

A team of scientists from the University of Pittsburgh and National Cancer Institute discovered why HIV is rarely the direct cause of cancer. The research found that it requires a specific series of events involving changes in HIV and additional mutations in human genes, resulting in T cell lymphomas. However, the occurrence is rare, a...

SourceUniversity of Pittsburgh·JournalScience Advances·DateOct 13, 2021

Mitigating lung damage, mortality due to SARS-CoV-2

A pre-clinical study by University of Illinois Chicago researchers shows that a drug targeting specific immune pathways can prevent lung damage and death in mice infected with the SARS-CoV-2 virus. The study suggests targeted treatments may be more suitable for COVID-19 patients than broad immune suppressants.

SourceUniversity of Illinois Chicago·JournalArteriosclerosis Thrombosis and Vascular Biology·TypeExperimental study·DateOct 5, 2021

Study suggests R rate for tracking pandemic should be dropped in favour of ‘nowcasts’

A new study by University of Cambridge researchers proposes abandoning the R rate for tracking pandemics in favor of nowcasts, which forecast daily new cases and deaths based on growth rates. The Harvey-Kattuman model has already proved accurate and effective in predicting COVID-19 waves and spikes worldwide.

SourceUniversity of Cambridge·JournalJournal of The Royal Society Interface·TypeData/statistical analysis·DateSep 28, 2021

Rates of infectious disease linked to authoritarian attitudes and governance – study

A new study reveals a strong connection between infection rates and strains of authoritarianism in public attitudes and politics. The research found that the more infectious US cities and states had more authoritarian-leaning citizens, with correlations between higher disease rates and conservative voting patterns.

SourceUniversity of Cambridge·JournalJournal of Social and Political Psychology·TypeExperimental study·DateSep 21, 2021

A novel malaria vaccine vector – target to the liver

Researchers at Kanazawa University have identified a new vaccine platform that targets liver cells to induce anti-malaria immunity. The AAV8 vaccine platform was found to be more effective in eliciting a T cell-mediated response in the liver, providing sterile protection against malaria in a murine model.

SourceKanazawa University·JournalFrontiers in Immunology·DateSep 16, 2021

Ground-breaking bacteria-killing viruses unite with antibiotics to fight devastating antibiotic-resistant bacteria

Scientists have developed a new therapy that combines bacteriophages with antibiotics to treat antibiotic-resistant infections, specifically targeting Mycobacterium abscessus. The treatment, using the bacteriophage 'Muddy', showed significant improvement in survival rates and severity of infections when paired with rifabutin, demonstra...

SourceThe Company of Biologists·JournalDisease Models & Mechanisms·TypeExperimental study·DateSep 16, 2021

Call for healthcare leaders to ensure women and girls have access to safe and affordable menstrual products and health

The need for public engagement on menstrual health is emphasized by a commentary in JAMA, highlighting the importance of sufficient funding and research. Menstrual equity is recognized as a human rights and public health issue with significant disparities affecting schoolgirls, women, and those experiencing homelessness.

Severe malaria among young African children dramatically reduced through seasonal vaccination and preventative drug combination

A new study published in the New England Journal of Medicine found that a combination of seasonal vaccination with RTS,S/AS01 E and antimalarial drugs significantly reduces clinical episodes, hospital admissions, and deaths from malaria. The results show a 70% reduction in these outcomes compared to current interventions.

SourceLondon School of Hygiene & Tropical Medicine·TypeRandomized controlled/clinical trial·DateAug 25, 2021

A new approach to curing HIV

A new strategy for curing HIV targets latent viruses by blocking and excising the virus, offering hope for patients to be taken off daily treatments. The HOPE Collaboratory's approach uses genome editing technology to destroy latent HIV.

Contact tracing is key to suppressing COVID-19

A new University of Georgia study models the impact of three interventions - social distancing, contact tracing, and case isolation - on containing COVID-19. The researchers found that robust contact tracing was essential in suppressing outbreaks, with a significant increase in cases when efforts were less efficient.

SourceUniversity of Georgia·JournalEpidemics·TypeComputational simulation/modeling·DateAug 17, 2021

A COVID-19 vaccine strategy to give the body ‘border protection’

A new research strategy enhances COVID-19 vaccine effectiveness by providing 'border protection' immunity in the nose, mouth and blood. The approach involves suppressing an enzyme that breaks down both pathogens and immune cells, resulting in a robust antibody response and improved protection against infections.

SourceOhio State University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateAug 11, 2021

Lyme Disease Heightens Risk of Mental Disorders, Suicidality

Patients with Lyme disease have a 28% higher rate of mental disorders and are twice as likely to attempt suicide compared to those without the diagnosis. The study reveals that having multiple episodes of Lyme disease is associated with a higher risk of mental health problems, including depression and suicidal behavior.

SourceColumbia University Irving Medical Center·JournalAmerican Journal of Psychiatry·TypeMeta-analysis·DateAug 10, 2021

Two PrEP medications are now available. Equally safe/effective. The biggest difference? The price tag.

A new study found that only 7% of patients who switched from Truvada to Descovy had a documented clinical reason for doing so, highlighting the need for cost-effective PrEP options. The significant price difference between the two medications may be a major barrier to broad and equitable PrEP use in the US.

SourceHarvard Pilgrim Health Care Institute·JournalOpen Forum Infectious Diseases·DateAug 5, 2021

Antibody findings spark ideas for pan-coronavirus vaccine

Scientists identified five human monoclonal antibodies that can neutralize multiple beta-coronaviruses by targeting a conserved structure in the spike protein. These antibodies showed promise in reducing viral load and enhancing immune responses in hamsters, providing potential inspiration for broadly protective vaccines.

SourceUniversity of Washington School of Medicine/UW Medicine·JournalScience·TypeExperimental study·DateAug 5, 2021

First 3-D view of TB granulomas alters paradigm of their shape and formation

Researchers created a 3D view of diseased lung tissue using microCT to reveal that TB granulomas are complex and branched, with unique connections to airways. This has significant implications for treatment, including the potential for aerosolized drug delivery to reduce treatment times.

SourceUniversity of Alabama at Birmingham·JournalAmerican Journal of Respiratory and Critical Care Medicine·TypeExperimental study·DateJul 28, 2021

Mortality rate higher for US rural residents

A recent study by Syracuse University professor Shannon Monnat found that mortality rates are higher for U.S. working-age residents living in rural areas compared to metro areas. The gap is widening, driven by increased mortality from metabolic and respiratory diseases, suicide, alcohol-related disorders, and mental/behavioral disorders.

SourceSyracuse University·JournalPopulation Research and Policy Review·DateOct 20, 2020